Quest Laboratories Limited (NSEI: QUESTLAB)
Health Care · Pharmaceuticals · IN
Rs91.45
+1.95% today · -7.3% 1Y
Quest Laboratories Limited (NSEI: QUESTLAB) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $15.67M and employs 200 people.
Over the last twelve months the share price has lost 7.3%, trading between 84.00 and 152.60.
Tweenvest scores Quest Laboratories Limited across four factors: quality 65/100, value 57/100, growth 97/100. Its strongest factor is growth.
QUESTLAB price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $15.67M
- Revenue (TTM)
- $14.01M
- P/E
- 9.22
- EPS
- 9.92
- Dividend yield
- —
- Beta (5Y)
- 0.97
- 52-week high
- Rs152.60
- 52-week low
- Rs84.00
- Avg volume (3M)
- —
- Shares outstanding
- 16.39M
- Employees
- 200
- Next earnings
- —
About Quest Laboratories Limited
Quest Laboratories Ltd. is a pharmaceutical company that specializes in the manufacturing of a diverse range of pharmaceutical formulations. The company produces ethical, generic, and over-the-counter (OTC) drugs across various therapeutic segments, including antibiotics, antimalarials, anti-inflammatories, respiratory medications, diabetes treatments, antidepressants, antispasmodics, and antiemetics. These formulations are available in multiple forms such as tablets, liquid orals, dry syrups, powders including Oral Rehydration Salts (ORS), liquid externals, and ointments. Quest Laboratories also manufactures capsules, ampoules, and injections. The company serves target markets including institutional supplies, the domestic ethical market, contract manufacturing clients, and export markets, with a focus on expanding into global regions like North and South Asia.
- Founded
- 1994
- Listed since
- May 23, 2024
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.00 | +0.13% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.16 | +0.34% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.18 | -0.24% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.30 | -1.41% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.00 | -1.14% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.23% |
Figures last refreshed Aug 18, 2026.